Injury and Illness Surveillance at FIFA U-17 & U-20 Women's World Cups.

The primary objective is to provide an overview of the incidence and characteristics of time-loss injuries and illnesses during the FIFA U-20 and U-17 Women's World Cups in 2022.

Study Overview

Detailed Description

This research project will be performed at the FIFA U-20 Women's World Cup 2022 final tournament which is played in Alajuela and San José, Costa Rica between August 10 and August 28, 2022, and the FIFA U-17 Women's World Cup 2022 final tournament which is played in Bhubaneswar, Goa, and Navi Mumbai, India between October 11 and October 30th, 2022.

Each tournament includes 16 national teams, and each team is allowed to select 21 players, giving at total of 336 potential participants per tournament. In total, 32 matches will be played over 19 days, with the 24 group stage matches played in the first 8 days and the 8 knock-out matches played in the last 9 days.

Study duration The study will start from the first day of training with the national team prior the tournament until the day of the last match of the tournament. Consequently, the number of recordings will vary between teams depending on the duration of their pre-tournament training (usually 1-3 weeks), and their performance and progression through the tournament. In order to assess the severity of injuries (based on the length of time a player is unable to play for), all injuries are to be recorded until they are fully rehabilitated, even if this is after the end of the tournament. Each contact person therefore also needs to report when an injured player who has left the tournament has returned to full training with their club team after the tournament.

Demographic information Individual demographic information, including age, height, weight, playing position, and leg dominance (preferred kicking leg), is collected following inclusion.

Injury & illness registration Data on injury and illness is gathered following the recommended methodology in the football extension of the International Olympic Committee consensus statement on methods for recording and reporting of epidemiological data on injury and illness in sport.10 This includes characteristics such as mode of onset, injury mechanism, diagnosis and classification according to body area, tissue, and pathology type, and illness categories for organ system and etiology. Time-loss will be counted in number of days.

Exposure registration Training and match exposure will be recorded in minutes for each participant on a weekly basis for the duration of the tournament. Training exposure includes for example any sports-specific training, strength and conditioning sessions, and active recovery sessions. Illness exposure will be recorded in days for each participant from their first day of training until their last match.

The primary objective is to provide an overview of the incidence and characteristics of time-loss injuries and illnesses during the FIFA U-20 and U-17 Women's World Cups in 2022.

A secondary objective is to explore any differences in injury characteristics between the two age categories.

The primary variables of interest are time-loss injuries and time-loss illnesses.

  • Time-loss is defined as inability of a player to complete the current or future training session or match.
  • Injury is defined as tissue damage or other derangement of normal physical function resulting from rapid or repetitive transfer of kinetic energy.
  • Illness is defined as a health-related complaint or disorder experienced by an athlete, not considered as an injury.

Descriptive statistics is used to provide an overview of the participant demographics and injury and illness occurrence. Injury incidence is calculated as number of injuries per 1000 hours of exposure, and injury burden is calculated as time-loss days per 1000 hours of exposure. Injury incidence and burden will be reported for training and match injuries separately. Illness incidence is calculated per 365 exposure days. Potential age group comparison in burden will be performed using an independent t-test/Mann-Whitney U Test depending on data distribution. Potential missing data will be excluded from analysis and reported accordingly.

Sample size No a priori sample size calculation is performed as we will attempt to include all eligible participants from the two tournaments giving a total possible sample size of 672 female football players.

Study Type

Observational

Enrollment (Estimated)

672

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zürich, Switzerland, 8044
        • Fédération Internationale de Football Association

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 20 years (Child, Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

This research project will be performed at the FIFA U-20 Women's World Cup 2022 final tournament which is played in Alajuela and San José, Costa Rica between August 10 and August 28, 2022, and the FIFA U-17 Women's World Cup 2022 final tournament which is played in Bhubaneswar, Goa, and Navi Mumbai, India between October 11 and October 30th, 2022.

Each tournament includes 16 national teams, and each team is allowed to select 21 players, giving at total of 336 potential participants per tournament. In total, 32 matches will be played over 19 days, with the 24 group stage matches played in the first 8 days and the 8 knock-out matches played in the last 9 days.

Description

Inclusion Criteria:

  • All participating football players at the FIFA U-20 and U-17 Women's World Cup 2022.

Exclusion Criteria:

  • No exclusion criteria are present except refusal to provide consent for data to me used in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Football players at the FIFA U-20 Women's World Cup 2022.
  • Upper age limit: all players must be a maximum of 20 years old by the end of the calendar year in which the World Cup 2022 is played (i.e. all players of the teams were born on or after 1 January 2002).
  • Lower age limit: all players must be at least 16 years old by the end of the calendar year in which the World Cup 2022 is played (i.e. all players of the teams were born on or before 31 December 2006).

Injury & illness registration

Data on injury and illness is gathered following the recommended methodology in the football extension of the International Olympic Committee consensus statement on methods for recording and reporting of epidemiological data on injury and illness in sport. This includes characteristics such as mode of onset, injury mechanism, diagnosis and classification according to body area, tissue, and pathology type, and illness categories for organ system and etiology. Time-loss will be counted in number of days.

Football players at the FIFA U-17 Women's World Cup 2022.
  • Upper age limit: all players must be a maximum of 17 years old by the end of the calendar year in which the World Cup 2022 is played (i.e. all players of the teams were born on or after 1 January 2005).
  • Lower age limit: all players must be at least 15 years old by the end of the calendar year in which the World Cup 2022 is played (i.e. all players of the teams were born on or before 31 December 2007).

Injury & illness registration

Data on injury and illness is gathered following the recommended methodology in the football extension of the International Olympic Committee consensus statement on methods for recording and reporting of epidemiological data on injury and illness in sport. This includes characteristics such as mode of onset, injury mechanism, diagnosis and classification according to body area, tissue, and pathology type, and illness categories for organ system and etiology. Time-loss will be counted in number of days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time-loss injury
Time Frame: August 2022
  • Time-loss is defined as inability of a player to complete the current or future training session or match.
  • Injury is defined as tissue damage or other derangement of normal physical function resulting from rapid or repetitive transfer of kinetic energy.
August 2022
Time-loss illness
Time Frame: October 2022
  • Time-loss is defined as inability of a player to complete the current or future training session or match.
  • Illness is defined as a health-related complaint or disorder experienced by an athlete, not considered as an injury.
October 2022

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andreas Serner, PhD, Fédération Internationale de Football Association

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2022

Primary Completion (Actual)

October 31, 2022

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

August 3, 2022

First Submitted That Met QC Criteria

August 3, 2022

First Posted (Actual)

August 4, 2022

Study Record Updates

Last Update Posted (Estimated)

March 4, 2024

Last Update Submitted That Met QC Criteria

March 1, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1 (Other Identifier: Mobile Health and Wellness Program)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Injuries

Clinical Trials on Registration of football exposure and occurrence of injuries and illnesses only

Subscribe